Dimensional Fund Advisors LP Has $267.57 Million Holdings in Cigna Corporation (CI)

Dimensional Fund Advisors LP raised its holdings in shares of Cigna Corporation (NYSE:CI) by 3.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,431,295 shares of the health services provider’s stock after acquiring an additional 49,879 shares during the quarter. Dimensional Fund Advisors LP owned about 0.58% of Cigna worth $267,567,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of CI. Capstone Investment Advisors Netherlands B.V. bought a new stake in Cigna during the 2nd quarter valued at $106,000. Saratoga Research & Investment Management bought a new stake in Cigna during the 3rd quarter valued at $112,000. Horan Capital Advisors LLC. bought a new stake in Cigna during the 3rd quarter valued at $123,000. Parallel Advisors LLC raised its holdings in Cigna by 62.3% during the 2nd quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock valued at $139,000 after acquiring an additional 307 shares during the period. Finally, Acrospire Investment Management LLC raised its holdings in Cigna by 66.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock valued at $167,000 after acquiring an additional 400 shares during the period. 87.85% of the stock is currently owned by institutional investors and hedge funds.

Cigna Corporation (NYSE:CI) opened at $209.97 on Friday. Cigna Corporation has a 1 year low of $131.03 and a 1 year high of $212.46. The stock has a market cap of $51,768.11, a price-to-earnings ratio of 20.23, a P/E/G ratio of 1.60 and a beta of 0.50. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39.

Cigna (NYSE:CI) last announced its earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.36 by $0.47. Cigna had a net margin of 5.74% and a return on equity of 18.85%. The company had revenue of $10.38 billion during the quarter, compared to analyst estimates of $10.17 billion. During the same period in the previous year, the business earned $1.94 earnings per share. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. analysts predict that Cigna Corporation will post 10.34 EPS for the current fiscal year.

In related news, Chairman Isaiah Harris, Jr. sold 247 shares of the company’s stock in a transaction on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total value of $45,761.69. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William D. Zollars sold 1,232 shares of the company’s stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total transaction of $230,667.36. The disclosure for this sale can be found here. Insiders sold 36,203 shares of company stock valued at $7,211,251 over the last quarter. 1.30% of the stock is owned by company insiders.

A number of research firms have recently commented on CI. Piper Jaffray Companies restated a “buy” rating and set a $191.00 price target on shares of Cigna in a research report on Sunday, September 17th. BidaskClub upgraded shares of Cigna from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 18th. Royal Bank Of Canada restated an “outperform” rating and set a $220.00 price target (up from $185.00) on shares of Cigna in a research report on Friday, November 3rd. Credit Suisse Group began coverage on shares of Cigna in a research report on Thursday, November 2nd. They set an “outperform” rating and a $219.00 price target for the company. Finally, Morgan Stanley boosted their price target on shares of Cigna from $188.00 to $195.00 and gave the company an “overweight” rating in a research report on Thursday, August 17th. Three analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $201.50.

ILLEGAL ACTIVITY WARNING: “Dimensional Fund Advisors LP Has $267.57 Million Holdings in Cigna Corporation (CI)” was reported by Week Herald and is owned by of Week Herald. If you are viewing this report on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this report can be accessed at https://weekherald.com/2017/12/10/dimensional-fund-advisors-lp-has-267-57-million-holdings-in-cigna-corporation-ci.html.

Cigna Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply